menu
    • menu

    Company profile for ObsEva

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At ObsEva, our passion and expertise in reproductive health and pregnancy therapeutics is helping millions of women worldwide lead healthier and more fulfilling lives. ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ObsEvaSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Plan-Les-Ouates, Geneva 1228, CH
    Telephone
    Telephone
    +41 (0)22 552 3840
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.obseva.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/obseva-sa
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ObsEva Announces Delisting from SIX Swiss Exchange & Exemption
    ObsEva Announces Delisting from SIX Swiss Exchange & Exemption

    03 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/03/2856586/0/en/ObsEva-Announces-Delisting-from-SIX-Swiss-Exchange-and-Exemption-from-Certain-Obligations-Associated-with-the-Maintenance-of-Listin.html

    GLOBENEWSWIRE
    03 Apr 2024
    Share Share
    ObsEva Announces Update on Board of Directors
    ObsEva Announces Update on Board of Directors

    19 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/19/2848274/0/en/ObsEva-Announces-Update-on-Board-of-Directors.html

    GLOBENEWSWIRE
    19 Mar 2024
    Share Share
    ObsEva winds down and lays off staff as money, options run out
    ObsEva winds down and lays off staff as money, options run out

    28 Feb 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/obseva-winds-down-and-lays-all-staff-money-options-run-out

    FIERCE BIOTECH
    28 Feb 2024
    Share Share
    ObsEva Announces Wind-Down of Operations
    ObsEva Announces Wind-Down of Operations

    27 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/28/2836594/0/en/ObsEva-Announces-Wind-Down-of-Operations-and-Notifies-SIX-that-it-Will-Lack-the-Resources-to-Establish-Audited-IFRS-Financial-Statements-for-2023.html

    GLOBENEWSWIRE
    27 Feb 2024
    Share Share
    Geneva Court Grants Temporary Moratorium to ObsEva
    Geneva Court Grants Temporary Moratorium to ObsEva

    31 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/01/31/2820701/0/en/Geneva-Court-Grants-Temporary-Moratorium-to-ObsEva.html

    GLOBENEWSWIRE
    31 Jan 2024
    Share Share
    ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals
    ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals

    30 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/30/2788224/0/en/ObsEva-Announces-Application-for-a-Moratorium-to-Facilitate-Pivotal-Deals.html

    GLOBENEWSWIRE
    30 Nov 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search